5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diff...
5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
About this item
Full title
Author / Creator
Chen, Hang-Yu , Zhang, Wei-Long , Zhang, Lei , Yang, Ping , Li, Fang , Yang, Ze-Ruo , Wang, Jing , Pang, Meng , Hong, Yun , Yan, Changjian , Li, Wei , Liu, Jia , Xu, Nuo , Chen, Long , Xiao, Xiu-Bing , Qin, Yan , He, Xiao-Hui , Liu, Hui , Zhu, Hai-Chuan , He, Chuan , Lin, Jian and Jing, Hong-Mei
Publisher
Germany: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Germany: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Although R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) remains the standard chemotherapy regimen for diffuse large B cell lymphoma (DLBCL) patients, not all patients are responsive to the scheme, and there is no effective method to predict treatment response.
We utilized 5hmC-Seal to generate genome-wide 5hmC pro...
Alternative Titles
Full title
5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7879534
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7879534
Other Identifiers
ISSN
1868-7075,1868-7083
E-ISSN
1868-7083,1868-7075
DOI
10.1186/s13148-020-00973-8
